MedPath

福建太平洋制药有限公司

Ownership
-
Established
1992-10-14
Employees
-
Market Cap
-
Website
www.pacific-pharmacy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Ibuprofen Suspension

Product Name
布洛芬混悬液
Approval Number
国药准字H20253472
Approval Date
Feb 25, 2025
NMPA

Montmorillonite Powder

Product Name
蒙脱石散
Approval Number
国药准字H20249259
Approval Date
Nov 5, 2024
NMPA

Ketoconazole Cream

Product Name
酮康唑乳膏
Approval Number
国药准字H19983244
Approval Date
Sep 23, 2024
NMPA

Triamcinolone Acetonide Acetate and Miconazole Nitrate and Neomycin Sulfate Cream

Product Name
曲咪新乳膏
Approval Number
国药准字H35021283
Approval Date
Aug 14, 2024
NMPA

Compound Paracetamol and Amantadine Hydrochloride Capsules

Product Name
复方氨酚烷胺胶囊
Approval Number
国药准字H20094227
Approval Date
May 6, 2024
NMPA

Ibuprofen Sustained-release Capsules

Product Name
布洛芬缓释胶囊
Approval Number
国药准字H20093691
Approval Date
Feb 29, 2024
NMPA

Loratadine Syrup

Product Name
氯雷他定糖浆
Approval Number
国药准字H20243068
Approval Date
Jan 23, 2024
NMPA

抗骨增生片

Approval Number
国药准字Z20083217
Approval Date
Jan 10, 2023
NMPA

Roxithromycin Capsules

Product Name
罗红霉素胶囊
Approval Number
国药准字H20083006
Approval Date
Apr 27, 2022
NMPA

Urea and Vitamin E Cream

Product Name
尿素维E乳膏
Approval Number
国药准字H20064291
Approval Date
Jan 8, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.